Hospitalist Doctors in Aiea, HI Accepting Medicare

2 Hospitalist doctors found. Showing 1 - 2

Andrea Marcella Bernhard, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 361-212-5854

Dr. Teodora Topalovski, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd., First Floor, Medical Staff Services, Pali Momi Medical, Aiea, HI 96701 Phone: 808-485-4109    Fax: 808-485-4124

News Archive

Keryx does not meet primary endpoint in perifosine + capecitabine Phase 3 trial for colorectal cancer

Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.

People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination

People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors -; a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions -; generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people and those on other kinds of immunosuppressants, according to a study by researchers at Washington University School of Medicine in St. Louis.

COVID-19 modeling shows that social distancing is a must, must, must

A new study shows that using mathematical modeling and accounting for several factors such as age distribution and density of the population, a clearer picture of COVID-19 infection in a population could be gained. The study titled, "Level of under-reporting including under-diagnosis before the first peak of COVID-19 in various countries: Preliminary Retrospective Results Based on Wavelets and Deterministic Modeling," is published as an accepted manuscript in the journal Infection Control & Hospital Epidemiology.

Novel assay can accurately detect prostate cancer than traditional screening

new prostate screening test developed by AnalizaDx, Inc., a Cleveland-based biotech company, and studied by researchers at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center along with colleagues at the Cleveland Clinic, the Veterans Administration Boston Healthcare and the National Cancer Institute, may prove to be a promising new tool in the diagnosis of prostate cancer.

Tips to redress health insurance plan problems

If you have a problem with your health insurance plan, there are steps you can take to get the service you need. California's Office of the Patient Advocate encourages Californians to speak up if they are having problems with their health plan and report any complaints. Start by explaining your problem to your doctor and your health insurance plan.

Read more Medical News

› Verified 6 days ago